News

Benefits seen for obesity, type 2 diabetes and related comorbidities, in addition to improvement in patients' quality of life and eating behavior

Significant weight loss, improvement in pulse pressure, normalization of depressive symptoms observed with salt restriction

Significant reduction seen in HbA1c with empagliflozin, but not linagliptin, versus placebo

Prevalence of diabetic retinopathy increased over time since diagnosis, reaching 28.14 percent at more than five years since diagnosis

Increase in risk for gestational diabetes in British Columbia attenuated after accounting for changes in screening methods

Greater percentage of time with glucose level in target range seen for young children using closed-loop system

Erythritol linked to incident MACE risk and enhances platelet reactivity and thrombosis formation

Elevated preconception glucose levels highest among women with limited access to and use of health care

During weight loss intervention, those with better sleep were more likely to follow caloric intake and exercise recommendations

Increase seen in prevalence of diabetes and obesity, no improvement in prevalence of hypertension for U.S. adults aged 20 to 44 years